Evidence map›Paper›PMID 11427708›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

A growth-constrained environment drives tumor progression invivo.

S Laconi, P Pani, S Pillai, D Pasciu, D S Sarma, E Laconi

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 55 citations in OpenAlex.

  1. Stem cell-based therapeutic strategies for liver aging.Liver research (Beijing, China) · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Cell competition in liver carcinogenesis.World journal of hepatology · 2020
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Inhibition effects of scorpion venom extracts (Buthus matensii Karsch) on the growth of human breast cancer MCF-7 cells.African journal of traditional, complementary, and alternative medicines : AJTCAM · 2014
    Article
  13. Article
  14. DNA damage checkpoints in stem cells, ageing and cancer.Nature reviews. Molecular cell biology · 2012
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

S LaconiDepartment of Medical Sciences and Biotechnology, University of Cagliari, 09125 Cagliari, Italy.
P Pani
S Pillai
D Pasciu
D S Sarma
E Laconi
University of Cagliari · ITUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently have shown that selective growth of transplanted normal hepatocytes can be achieved in a setting of cell cycle block of endogenous parenchymal cells. Thus, massive proliferation of donor-derived normal hepatocytes was observed in the liver of rats previously given retrorsine (RS), a naturally occurring alkaloid that blocks proliferation of resident liver cells. In the present study, the fate of nodular hepatocytes transplanted into RS-treated or normal syngeneic recipients was followed. The dipeptidyl peptidase type IV-deficient (DPPIV(-)) rat model for hepatocyte transplantation was used to distinguish donor-derived cells from recipient cells. Hepatocyte nodules were chemically induced in Fischer 344, DPPIV(+) rats; livers were then perfused and larger (>5 mm) nodules were separated from surrounding tissue. Cells isolated from either tissue were then injected into normal or RS-treated DPPIV(-) recipients. One month after transplantation, grossly visible nodules (2--3 mm) were seen in RS-treated recipients transplanted with nodular cells. They grew rapidly, occupying 80--90% of the host liver at 2 months, and progressed to hepatocellular carcinoma within 4 months. By contrast, no liver nodules developed within 6 months when nodular hepatocytes were injected into the liver of recipients not exposed to RS, although small clusters of donor-derived cells were present in these animals. Taken together, these results directly point to a fundamental role played by the host environment in modulating the growth and the progression rate of altered cells during carcinogenesis. In particular, they indicate that conditions associated with growth constraint of the host tissue can drive tumor progression in vivo.

Indexed as

Cell Transformation, NeoplasticAnimalsAntineoplastic Agents, PhytogenicCarcinoma, HepatocellularCell DivisionCell TransplantationDipeptidyl Peptidase 4LiverLiver Neoplasms, ExperimentalMalePyrrolizidine AlkaloidsRatsRats, Inbred F344Antineoplastic Agents, PhytogenicDipeptidyl Peptidase 4Pyrrolizidine Alkaloidsretrorsine

Identifiers

PMID11427708
PMCPMC35423
OpenAlexW2034269651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.